Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Piedad, Ussetti"'
Autor:
Meritxell Boada-Pérez, Victoria Ruiz de Miguel, Marta Erro, Piedad Ussetti, Myriam Aguilar, Raquel Castejón, Silvia Rosado, Roser Escobar-Fornieles, Eva Revilla-López, Carlos Bravo, Berta Sáez-Giménez, Marta Zapata-Ortega, Yolanda Villena-Ortiz, Jaume Vima-Bofarull, Víctor Monforte, Susana Gómez-Ollés
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionTrough blood levels (C0) of tacrolimus are used to adjust drug dosage, but they do not consistently correlate with clinical outcomes. Measurement of residual gene expression of nuclear factor of activated T cell (NFAT)-regulated genes (NF
Externí odkaz:
https://doaj.org/article/a73568c28b8d45418b06bdd6c0b80074
Autor:
Silvia Aguado Ibáñez, Rosalía Laporta Hernández, Myriam Aguilar Pérez, Christian García Fadul, Cristina López García Gallo, Gema Díaz Nuevo, Sonia Salinas Castillo, Raquel Castejón Diaz, Clara Salas Anton, Ana Royuela Vicente, Francisco Antonio Bernabeu Andreu, María Piedad Ussetti Gil
Publikováno v:
Transplantology, Vol 4, Iss 3, Pp 102-110 (2023)
The usefulness of bronchoalveolar lavage fluid (BALF) to support the diagnosis of acute cellular (ACR) rejection in lung transplant (LTX) recipients remains controversial. ACR has been associated with blood eosinophil counts (EOS) in other solid orga
Externí odkaz:
https://doaj.org/article/b684098613034ddb84350f0fa406385d
Autor:
Rosa Gutiérrez-Larraya-Sánchez-Andrade, Marta Erro-Iribarren, Silvia Aguado-Ibáñez, Myriam Aguilar-Pérez, Rosalía Laporta-Hernández, Cristina López-García-Gallo, Carlos Almonacid-Sánchez, Piedad Ussetti-Gil
Publikováno v:
Revista de Patología Respiratoria, Vol 27, Iss 1 (2024)
Antecedentes: Los trasplantados pulmonares son un grupo con mayor riesgo de desarrollar enfermedad por coronavirus 2019 (COVID-19) grave. El sotrovimab demostró reducir el riesgo de progresión de enfermedad y ha sido utilizado en pacientes con tras
Externí odkaz:
https://doaj.org/article/04efd9c9dbc04e5c96f8505be382a048
Publikováno v:
Barcelona Respiratory Network Reviews, Vol 9, Iss 3 (2023)
There is increasing interest in the development of biomarkers of acute cellular rejection (ACR) and chronic allograft dysfunction (CLAD) in lung transplant recipients. However, few studies have focused on the predictive value of cellular biomarkers u
Externí odkaz:
https://doaj.org/article/43fdaa1025bf445a99b6330d10c7b2ff
Autor:
Ignacio Darnaude-Ximénez, Antonio F Caballero-Bermejo, Belén Ruiz-Antorán, Myriam Aguilar-Pérez, Alicia Gómez-López, Aranzazu Sancho-López, Cristian García-Fadul, Elena Diago-Sempere, Manuel Valle Falcones, Piedad Ussetti-Gil, Cristina Avendaño-Solá
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 9, p e37275 (2022)
BackgroundAspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole (ISA) has shown a better safety profile and noninferiority to voriconazole in the treatment of patients with IFD. Obje
Externí odkaz:
https://doaj.org/article/ad7b452043234a94aec8e2f59f0eb624
Autor:
Nikolaus Kneidinger, Alessandro Ghiani, Katrin Milger, Víctor Monforte, Christiane Knoop, Peter Jaksch, Jasvir Parmar, Piedad Ussetti, Amparo Solé, Joachim Müller-Quernheim, Andreas Voelp, Juergen Behr, Claus Neurohr
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundChronic lung allograft dysfunction (CLAD) is defined by a progressive loss of FEV1 and is associated with premature mortality. The aim of this study was to investigate the direct association between FEV1 decline and risk of mortality in pat
Externí odkaz:
https://doaj.org/article/62a6d98c5fd8496dbf28b19f3df19e52
Autor:
Xavier Farré, Roderic Espín, Alexandra Baiges, Eline Blommaert, Wonji Kim, Krinio Giannikou, Carmen Herranz, Antonio Román, Berta Sáez, Álvaro Casanova, Julio Ancochea, Claudia Valenzuela, Piedad Ussetti, Rosalía Laporta, José A. Rodríguez-Portal, Coline H.M. van Moorsel, Joanne J. van der Vis, Marian J.R. Quanjel, Mireia Tena-Garitaonaindia, Fermín Sánchez de Medina, Francesca Mateo, María Molina-Molina, Sungho Won, David J. Kwiatkowski, Rafael de Cid, Miquel Angel Pujana
Publikováno v:
ERJ Open Research, Vol 8, Iss 1 (2022)
Introduction Lymphangioleiomyomatosis (LAM) is a rare low-grade metastasising disease characterised by cystic lung destruction. The genetic basis of LAM remains incompletely determined, and the disease cell-of-origin is uncertain. We analysed the pos
Externí odkaz:
https://doaj.org/article/4e9a4cf72a5842a4b50c1251e63fb295
Autor:
Marjorie Vieira Batista, Maria Piedad Ussetti, Ying Jiang, Dionysios Neofytos, Anita Cassoli Cortez, Diego Feriani, Jayr Schmidt-Filho, Ivan Leonardo Avelino França-Silva, Issam Raad, Ray Hachem
Publikováno v:
Journal of Fungi, Vol 9, Iss 2, p 166 (2023)
Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among immunocompromised patients with underlying malignancies and prior transplants. FDA approved Isavuconazole as a primary therapy for Invasive Aspergillosis (IA) and Mu
Externí odkaz:
https://doaj.org/article/ff0ec8b3f1924e969556d82ed3cb660c
Autor:
Víctor M. Mora, Piedad Ussetti, Alicia de Pablo, David Iturbe, Rosalía Laporta, Rodrigo Alonso, Myriam Aguilar, Carlos A. Quezada, José M. Cifrián
Publikováno v:
Microorganisms, Vol 11, Iss 1, p 32 (2022)
Background: The clinical benefits of the common off-label use of cytomegalovirus (CMV)-specific immunoglobulin (CMV-Ig) combined with antivirals in organ transplantation have not been previously assessed. The objective was to compare the risk of CMV
Externí odkaz:
https://doaj.org/article/88a4936d25d44e90ab118a347da0c981
Autor:
Carmen Herranz, Francesca Mateo, Alexandra Baiges, Gorka Ruiz de Garibay, Alexandra Junza, Simon R Johnson, Suzanne Miller, Nadia García, Jordi Capellades, Antonio Gómez, August Vidal, Luis Palomero, Roderic Espín, Ana I Extremera, Eline Blommaert, Eva Revilla‐López, Berta Saez, Susana Gómez‐Ollés, Julio Ancochea, Claudia Valenzuela, Tamara Alonso, Piedad Ussetti, Rosalía Laporta, Antoni Xaubet, José A Rodríguez‐Portal, Ana Montes‐Worboys, Carlos Machahua, Jaume Bordas, Javier A Menendez, Josep M Cruzado, Roser Guiteras, Christophe Bontoux, Concettina La Motta, Aleix Noguera‐Castells, Mario Mancino, Enrique Lastra, Raúl Rigo‐Bonnin, Jose C Perales, Francesc Viñals, Alvaro Lahiguera, Xiaohu Zhang, Daniel Cuadras, Coline H M vanMoorsel, Joanne J van derVis, Marian J R Quanjel, Harilaos Filippakis, Razq Hakem, Chiara Gorrini, Marc Ferrer, Aslihan Ugun‐Klusek, Ellen Billett, Elżbieta Radzikowska, Álvaro Casanova, María Molina‐Molina, Antonio Roman, Oscar Yanes, Miquel A Pujana
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 9, Pp n/a-n/a (2021)
Abstract Inhibition of mTOR is the standard of care for lymphangioleiomyomatosis (LAM). However, this therapy has variable tolerability and some patients show progressive decline of lung function despite treatment. LAM diagnosis and monitoring can al
Externí odkaz:
https://doaj.org/article/51f572bcdff644bcab3c3cc538fd0d47